Natural Herb May be Key to Eradicating Cancer Cells

Tripterygium wilfordii

The key to curing the type of pancreatic cancer that afflicted Apple Computers visionary Steve Jobs just might be found in an ancient Chinese herb that has long played a crucial role in traditional Chinese medicine.

A new study published in the journal Science Translational Medicine has revealed that lei gong teng, also known as “thunder god vine,” possesses at least one unique compound capable of fully eradicating cancer tumors within 40 days, which could eventually make the herb the go-to alternative for treating the disease.

A research team from the University of Minnesota’s Masonic Cancer Center discovered that when given an injectable extract form of  lei gong teng, also known as  tripterygium wilfordii, mice with pancreatic tumors experienced complete healing and recovery in less than five weeks. Even after discontinuing the treatment, the healed mice indefinitely maintained their healthy, cancer-free state with no signs of tumor resurgence or relapse.

The lei gong teng compound believed to be primarily responsible for killing cancer tumors is triptolide, an active diterpenoid that has been shown in several previous studies to exhibit broad anti-cancer activity. The team was able to effectively isolate the triptolide and convert it into a water soluble form, which researchers then injected into the mice regularly for a little more than one month, which was enough to cure the animals’ cancers.

“This [herb] is just unbelievably potent in killing tumor cells,” said Ashok Saluja, vice chairman of research at the center,  about the findings. “You could see that every day you looked at those mice, the tumor was decreasing and decreasing, and then just gone.”

Back in 2007, researchers from both Yale and Columbia universities found that triptolide effectively triggers cancer cell apoptosis or programmed cell death. Many other studies over the years have also identified triptolide as a powerful tumor fighter in a general sense, including as a weapon against aggressive prostate cancers.

Read more: Natural News

Still independent.

We hope this story was worth your time. For over 14 years, Atlanta Black Star has stayed Black-owned and independently run. We didn't get here by waiting on ad budgets that were never built to prioritize us. Our readers did that.

Corporate support for Black media has always been thin. Outlets like ours get roughly 1% of the $170 billion spent on U.S. advertising each year, and that margin is shrinking further as advertisers walk back the DEI-linked commitments they made in 2020. That's the backdrop. It's not why we're asking.

The wider picture isn't any steadier. Newspaper ad revenue has fallen more than 80% since 2005, and local newsrooms are closing at a rate of roughly two a week nationwide. When outlets go under, it's rarely the ones built to center a Black perspective from the ground up that get to stick around.

We know a request for support isn't why you came here. But without readers choosing to fund this work directly, the depth of reporting we can do at home and abroad shrinks along with everyone else's. If you're not in a position to give, that doesn't change how much we value you as a reader.

If you are able to, a recurring contribution does more for us than a single one-time gift, because it lets us plan the next investigation instead of just the next invoice. It takes about 30 seconds, no long form, no account. Thank you for continuing to support independent journalism and freedom of the press.

Back to top